Clinically studied systemic proteolytic enzymes for circulatory and cardiovascular support.*
What It Does
Lumbrokinase Circulatory Systemic Enzymes supports healthy blood flow, platelet function, and fibrin breakdown to promote optimal cardiovascular health.* These earthworm-derived proteolytic enzymes act systemically to help maintain blood viscosity and support the body's natural fibrinolytic pathways.*
How It Works
• Lumbrokinase (from Lumbricus rubellus): A group of six proteolytic enzymes that primarily target fibrin and fibrinogen, promoting healthy clot breakdown while sparing other plasma proteins.* [1-2]
• Systemic Enzyme Activity: Functions beyond digestion to support cardiovascular and circulatory health by enhancing the body’s natural fibrinolytic mechanisms.* [3]
• Evidence-Based Benefits: Multiple clinical studies, including trials at Beijing Xuanwu Hospital, have demonstrated support for normal circulation, blood flow, and vascular function.* [4-6]
• Delayed-Release Delivery: Encapsulated in acid-resistant, delayed-release capsules using gellan gum to protect enzyme activity as it passes through the stomach.*
Who It’s For
Ideal for individuals seeking support for circulatory health, fibrin balance, and systemic enzyme therapy to enhance cardiovascular wellness.*
Special Features
• Systemic Proteolytic Enzyme Formula: Specifically targets fibrin while sparing other essential plasma proteins like plasminogen and albumin.*
• Phthalate-Free Delayed Release: Gellan gum-based acid resistance ensures optimal enzyme delivery without synthetic coatings.*
• Traditional and Modern Integration: Earthworm-derived enzymes with a long history of use in Eastern medicine and validation through modern clinical research.*
Lumbrokinase Circulatory Systemic Enzymes deliver targeted, clinically researched systemic enzyme support for circulatory and cardiovascular health, with clean, delayed-release delivery to preserve activity and effectiveness.*
References
¹ Mihara H, et al. Jpn J Physiol. 1991;41(3):461-472. doi:10.2170/jjphysiol.41.461
² Nguyen QTT, et al. BioMed Res Int. 2023. doi:10.1155/2023/4050730
³ Verma NK, et al. Int J Bio-Sci Bio Tech. 2011;3(2).
⁴ Chen Y, et al. Trials. 2022;23(1). doi:10.1186/s13063-022-06200-4
⁵ Cao Y, et al. Chin Med J. 2013;126(21). doi:10.3760/cma.j.issn.0366-6999.20131332
⁶ Wiyarta E, et al. Stroke Vas Int Neurol. 2024;4(S1). doi:10.1161/svin.04.suppl_1.099
⁷ Kasim M, et al. J Altern Complement Med. 2009;15(5):539-544. doi:10.1089/acm.2008.0506
⁸ Sukmawan YP. Indones J Clin Pharm. 2020;9(1):43. doi:10.15416/ijcp.2020.9.1.43
